Insider trade

Trisalus Life Sciences (TLSI)Director bought ~$23K

Mats Wahlstrom, Director at Trisalus Life Sciences, bought ~$23K of Trisalus Life Sciences shares.

~$23K
Approx. value · 5,000 sh @ $4.55
16K
Holds after · shares reported
Traded
Nov 22, 2024
Filed
Nov 25, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 5, 2024InsiderOfficer sold ~$1.4K of TLSI shares in the open market
  2. Nov 20, 2024InsiderDirector purchased ~$8.5K of TLSI shares in the open market
  3. Nov 21, 2024InsiderDirector purchased ~$39K of TLSI shares in the open market
  4. Nov 22, 2024 · this disclosureInsiderDirector purchased ~$23K of TLSI shares in the open market

What came next

  1. Dec 10, 2024InsiderDirector sold ~$111K of TLSI shares in the open market
  2. Dec 17, 2024Insider10% owner purchased ~$250K of TLSI shares in the open market
  3. Jan 27, 2025Insider · 3 peopleInsiders: 3 purchases (~$235K)
  4. Jan 28, 2025Insider · 2 peopleInsiders: 2 purchases (~$102K)
  5. Jan 29, 2025InsiderCEO purchased ~$25K of TLSI shares in the open market
  6. Jan 30, 2025InsiderCEO purchased ~$26K of TLSI shares in the open market
  7. Feb 5, 2025InsiderCFO purchased ~$34K of TLSI shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Trisalus Life Sciences

For Trisalus Life Sciences, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TLSI page.

Other recent filings by Mats Wahlstrom, Director

The full history of Mats Wahlstrom, Director is on the profile page.

How this filing works

Other disclosures at Trisalus Life Sciences

Everything OQRO holds on this company is on its TLSI page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data